SHAREHOLDERS IN Ovoca Bio must be increasingly bewildered at the approach being taken by the Russians who control the company, where Kirill Golovanov is in situ as CEO. However, his strategy has apparently been endorsed by the company’s professional team, headed up by stockbrokers Davy and including solicitors Opus Partners and auditors Grant Thornton. The… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!